Quality standard

Quality statement 8: Follow-up and regular surveillance

Quality statement

People free from disease after treatment for colorectal cancer are offered regular surveillance.

Quality measure

Structure

Evidence of local arrangements to ensure people free from disease after treatment for colorectal cancer, are offered regular surveillance.

Data source: Local data collection.

Process

a) Proportion of people free from disease after treatment for colorectal cancer who receive 6-monthly blood carcinoembryonic antigen estimation (CEA) for 3 years after treatment.

Numerator – the number of people in the denominator who received CEA estimation no more than 6 months ago.

Denominator – the number of people who have been free from disease for 3 years or less after treatment for colorectal cancer.

Data source: Local data collection.

b) Proportion of people free from disease after treatment for colorectal cancer who receive at least 2 CT scans of the chest, abdomen and pelvis within 3 years of treatment for colorectal cancer.

Numerator – the number of people in the denominator who received at least 2 CT scans of the chest, abdomen and pelvis within 3 years of completion of treatment.

Denominator – the number of people who have had colorectal cancer who have been disease free for 3 years or more after completion of treatment.

Data source: Local data collection.

c) Proportion of people free from disease after colorectal resection who receive a clearance colonoscopy at 1 year and a surveillance colonoscopy at 3 years.

Numerator – the number of people in the denominator who receive a clearance colonoscopy at 1 year and a surveillance colonoscopy at 3 years after colorectal resection.

Denominator: the number of people who are free from disease for 1 year after colorectal resection.

Data source: Local data collection and British Society of Gastroenterology, the Association of Coloproctology of Great Britain and Ireland and Public Health England guidelines on post-polypectomy and post-colorectal cancer resection surveillance.

What the quality statement means for different audiences

Service providers ensure systems are in place for people free from disease after treatment for colorectal cancer to be offered regular surveillance.

Healthcare professionals offer regular surveillance to people free from disease after treatment for colorectal cancer.

Commissioners ensure they commission services for people free from disease after treatment for colorectal cancer that offers regular surveillance.

People with colorectal cancer who are disease free after treatment are offered regular check-ups and investigations to check for any signs of the disease returning.

Source guidance